PARIS–(BUSINESS WIRE)–Jan 5, 2023–
Sofinnova Partners (“Sofinnova”), a number one European life sciences enterprise capital agency primarily based in Paris, London, and Milan, introduced the appointment of Manohar (Mano) Iyer, a serial entrepreneur with longstanding ties to Sofinnova, as Venture Partner.
Mano Iyer (Photograph: Business Wire)
Mr. Iyer will examine world medical system funding alternatives throughout the Sofinnova Partners platform of methods, with a selected concentrate on serving to the agency’s in-house medtech accelerator, Sofinnova MD Begin, incubate world-class firms.
Mr. Iyer has greater than 25 years of expertise within the medical system trade. In 2008, he was a founding member of the unique MD Begin staff that incubated firms together with CorWave and LimFlow. He additionally suggested CoreValve, a Sofinnova Capital Technique portfolio firm, which was subsequently bought by Medtronic for $800 million.
Mr. Iyer based ReCor Medical throughout his time as an Entrepreneur-in-Residence at Sofinnova Partners in 2009. ReCor, one other Sofinnova Partners funding, which is growing an ultrasound renal denervation system to deal with hypertension, was efficiently offered to Otsuka Medical Gadgets in 2018. Mr. Iyer left Sofinnova in 2013 to work full-time because the Chief Working Officer of ReCor.
Antoine Papiernik, Chairman and Managing Partner of Sofinnova Partners, stated: “We’re delighted to have Mano again within the fold at Sofinnova Partners. He’s an skilled firm builder and a revered determine within the medical system group who has proven an uncanny capability to start out profitable firms it doesn’t matter what situation the worldwide economic system is in.”
Anne Osdoit, Partner at Sofinnova Partners, stated: “Mano joins us as MD Begin is basically hitting its stride. A number of of our firms are maturing exceptionally effectively and now we have a wholesome circulation of promising disruptive medtech initiatives. Mano brings a deep understanding of the sector because of his expertise and community within the US and Europe. He additionally is aware of our medtech acceleration mannequin inside out, having pioneered it with ReCor. We’re thrilled to be working with him.”
Mr. Iyer stated: “Sofinnova has realized one thing actually spectacular in growing a first-class medtech ecosystem primarily based out of Europe. The agency is acknowledged globally as an influential participant within the area and I’m excited and proud to be again.”
Mr. Iyer began his profession in medical gadgets as an engineer at Arrow Worldwide. Whereas at Arrow, he met Tim Lenihan. In 2001, he co-founded Contract Medical Worldwide (CMI) with Mr. Lenihan, and ran operations and engineering. CMI specialised within the improvement and customized manufacturing of minimally invasive medical system techniques. It was acquired by Heraeus Group in 2020.
After incomes an MBA from Stanford, he joined Sofinnova Partners because of an introduction from Gerard Hascoët, whom he had additionally met whereas at Arrow. The trio (Hascoët, Lenihan, Iyer) joined forces with Antoine Papiernik and, with the backing of Sofinnova Partners, based MD Begin to create and incubate revolutionary medical system firms. Now in its third iteration, MD Begin is absolutely built-in into the Sofinnova platform of methods.
Sofinnova Partners is a number one European enterprise capital agency in life sciences, specializing in healthcare and sustainability. Primarily based in Paris, London and Milan, the agency brings collectively a staff of pros from everywhere in the world with robust scientific, medical and enterprise experience. Sofinnova Partners is a hands-on firm builder throughout your complete worth chain of life sciences investments, from seed to later-stage. The agency actively companions with formidable entrepreneurs as a lead or cornerstone investor to develop transformative improvements which have the potential to positively affect our collective future.
Based in 1972, Sofinnova Partners is a deeply established enterprise capital agency in Europe, with 50 years of expertise backing over 500 firms and creating market leaders across the globe. As we speak, Sofinnova Partners has over €2.5 billion underneath administration. For extra info, please go to: sofinnovapartners.com.
INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH MEDICAL DEVICES OTHER SCIENCE FINANCE GENERAL HEALTH SCIENCE
SOURCE: Sofinnova Partners
Copyright Business Wire 2023.
PUB: 01/05/2023 04:00 AM/DISC: 01/05/2023 04:00 AM
